Posts Tagged ‘kidney’
Availability Of More Current Kidney Disease Data Announced By NIDDK
Incidence and prevalence data for end-stage kidney disease in the United States will be available online from the U.S. Renal Data System a year earlier than usual, announces the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. In addition, the data will be updated online every three months and will show quarterly counts of patients (
Medical Insurance Documents Shed Light On Kidney Transplant Patients’ Health
Billing claims from health insurance companies can provide insights on the long-term health of kidney transplant patients, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The findings indicate that valuable health information can be obtained by analyzing medical insurers’ reimbursement documents, a process that is much simpler and cheaper than many other forms of clinical investigation.
Novel DNA Vaccine Leads To Kidney Damage Prevention In Systemic Lupus Erythematosus Models
DNA vaccination using lupus autoantigens and interleukin-10 (IL-10, a cytokine that plays an important role in regulating the immune system) has potential as a novel therapy to induce antigen specific tolerance and may help to prevent kidney damage in patients with systemic lupus erythematosus, according to a new study.
New Medicare Policy May Pose Risks To Black Kidney Patients
A change in Medicare reimbursement policy could make it more difficult for African Americans with kidney disease to access dialysis services, suggests a study in an upcoming issue of the Journal of the American Society of Nephrology (JASN). “The change in payment policy may disadvantage a substantial group of dialysis patients,” comments Areef Ishani, MD (University of Minnesota).
Improved Care For Kidney Patients Reduces Medicare Costs And Saves Taxpayers Money
The cost to Medicare for managing chronic kidney disease (CKD) is high; however, IPRO is urging health care providers in New York to work together to both improve patient care and reduce costly complications from the disease. Medicare costs for CKD and end-stage renal disease (ESRD) exceed $70 billion annually according to United States Renal Data System (USRDS) data.
Rituximab Reduces Kidney Inflammation In Patients With Lupus
Treatment with the targeted drug rituximab can significantly benefit some patients with severe lupus nephritis who do not respond to conventional therapy, according to a new study. The findings indicate that this immunosuppressive agent could improve the health of patients who have few other treatment options and who might otherwise develop end-stage renal disease.
Measuring Quality Of Life In Patients With Hereditary Kidney Disease
A commonly used questionnaire that measures quality of life is not sensitive enough to pick up mental and physical problems experienced by patients with autosomal dominant polycystic kidney disease, according to a new study. Findings indicate that patients with this condition (the most common form of hereditary kidney disease) need better tests to adequately measure quality of life.
Rx Drug Compare
Translator
By N2H